March 12, 2016

 

endTB aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:

  • access to new drugs
  • two clinical trials
  • advocacy at national and global levels.

Covering 17 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partner UNITAID.

Watch the two-minute animation

 

You can follow us on Twitter.

Pakistan: endTB trial starts in Sindh province

Pakistan TB X-ray

 

30 October 2019

Pakistan: endTB trial starts in Sindh province

Read more

Second endTB Clinical Trial In-Person Meeting

Second endTB Clinical Trial In Person Meeting

 

24 February 2020

In February 2020, endTB investigators and study coordinators were invited to the endTB Clinical Trial In Person Meeting. 

Read more

PIH MSF MSF UNITAID